TP53 and T-cell non-Hodgkin lymphoma: Strikingly, all seven early-stage Rag2−/−OTII p53−/− T cell lymphomas carried the 9qA4-5.3 amplification at very high frequency (range = 80% to 100%, n = 331 metaphases analyzed) (Figures 3D and 3E; Table S5).